INHIBITION OF TOLBUTAMIDE ELIMINATION BY CIMETIDINE BUT NOT RANITIDINE

被引:20
作者
CATE, EW
ROGERS, JF
POWELL, JR
机构
[1] UNIV N CAROLINA,SCH PHARM,DIV PHARM PRACTICE,CHAPEL HILL,NC 27514
[2] UNIV N CAROLINA,SCH PHARM,DIV CLIN PHARMACOL,CHAPEL HILL,NC 27514
[3] UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27514
关键词
D O I
10.1002/j.1552-4604.1986.tb03540.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:372 / 377
页数:6
相关论文
共 22 条
[1]   INHIBITION OF TOLBUTAMIDE METABOLISM BY SUBSTITUTED IMIDAZOLE DRUGS INVIVO - EVIDENCE FOR A STRUCTURE-ACTIVITY RELATIONSHIP [J].
BACK, DJ ;
TJIA, JF .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 85 (01) :121-126
[2]   DOSE-DEPENDENT EFFECT OF CIMETIDINE ON PHENYTOIN KINETICS [J].
BARTLE, WR ;
WALKER, SE ;
SHAPERO, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (05) :649-655
[3]  
CHRISTENSEN LK, 1969, LANCET, V2, P1397
[4]  
DEANGELIS C, 1983, CLIN PHARMACY, V2, P563
[5]   THE EFFECT OF CIMETIDINE ON TOLBUTAMIDE KINETICS [J].
DEY, NG ;
CASTLEDEN, CM ;
WARD, J ;
CORNHILL, J ;
MCBURNEY, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (04) :438-440
[6]   THE INFLUENCE OF H-2-RECEPTOR ANTAGONISTS ON STEADY-STATE CONCENTRATIONS OF PROPRANOLOL AND 4-HYDROXYPROPRANOLOL [J].
DONN, KH ;
POWELL, JR ;
ROGERS, JF .
JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (11-1) :500-508
[7]  
EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[8]   FACTORS AFFECTING THE RESPONSE TO INHIBITION OF DRUG-METABOLISM BY CIMETIDINE DOSE-RESPONSE AND SENSITIVITY OF ELDERLY AND INDUCED SUBJECTS [J].
FEELY, J ;
PEREIRA, L ;
GUY, E ;
HOCKINGS, N .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (01) :77-81
[9]  
MCDANIEL HG, 1969, J PHARMACOL EXP THER, V167, P91
[10]   THE EFFECT OF SULPHINPYRAZONE ON OXIDATIVE DRUG-METABOLISM IN MAN - INHIBITION OF TOLBUTAMIDE ELIMINATION [J].
MINERS, JO ;
FOENANDER, T ;
WANWIMOLRUK, S ;
GALLUS, AS ;
BIRKETT, DJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (04) :321-326